| Issue Date | Title | Author(s) |
| 2021 | Berberine-Loaded Liquid Crystalline Nanoparticles Inhibit Non-Small Cell Lung Cancer Proliferation and Migration in Vitro | Paudel, KR; Mehta, M; Yin, GHS; Yen, LL; Malyla, V; Patel, VK; Panneerselvam, J; Madheswaran, T; MacLoughlin, R; Jha, NK; Gupta, PK; Singh, SK; Gupta, G; Kumar, P; Oliver, BG; Hansbro, PM; Chellappan, DK; Dua, K |
| 2022-02-01 | Discovering multifaceted role of vanillic acid beyond flavours: Nutraceutical and therapeutic potential | Kaur, J; Gulati, M; Singh, SK; Kuppusamy, G; Kapoor, B; Mishra, V; Gupta, S; Arshad, MF; Porwal, O; Jha, NK; Chaitanya, MVNL; Chellappan, DK; Gupta, G; Gupta, PK; Dua, K; Khursheed, R; Awasthi, A; Corrie, L |
| 2021-10 | Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an update | Krishnan, S; Thirunavukarasu, A; Jha, NK; Gahtori, R; Roy, AS; Dholpuria, S; Kesari, KK; Singh, SK; Dua, K; Gupta, PK |
| 2021-12-16 | Overcoming hydrolytic degradation challenges in topical delivery: Non-aqueous nano-emulsions. | Kadukkattil Ramanunny, A; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Khursheed, R; Kuppusamy, G; Dua, K; Dureja, H; Chellappan, DK; Jha, NK; Gupta, PK; Vishwas, S |
| - | Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development | Gupta, PK; Saraff, M; Gahtori, R; Negi, N; Tripathi, SK; Kumar, J; Kumar, S; Aldhayan, SH; Dhanasekaran, S; Abomughaid, MM; Dua, K; Gundamaraju, R; Ojha, S; Ruokolainen, J; Jha, NK; Kesari, KK |
| 2022-02-23 | Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling. | Jha, NK; Arfin, S; Jha, SK; Kar, R; Dey, A; Gundamaraju, R; Ashraf, GM; Gupta, PK; Dhanasekaran, S; Abomughaid, MM; Das, SS; Singh, SK; Dua, K; Roychoudhury, S; Kumar, D; Ruokolainen, J; Ojha, S; Kesari, KK |
| - | Role of HGF/MET in liver cancer | Gupta, G; Al-Malki, WH; Kazmi, I; Thangavelu, L; Gupta, PK; Jha, NK; Prasher, P; Singh, SK; Dua, K |
| 2021-09-13 | A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations. | Joshi, D; Sharma, I; Gupta, S; Singh, TG; Dhiman, S; Prashar, A; Gulati, M; Kumar, B; Vishwas, S; Chellappan, DK; Gupta, G; Jha, NK; Gupta, PK; Negi, P; Dua, K; Singh, SK |
| - | Mitigating inflammation using advanced drug delivery by targeting TNF-α in lung diseases | Das, SS; Singh, SK; Verma, PRP; Jha, NK; Gupta, PK; Dua, K |
| - | Exploring the role of antibiotics and steroids in managing respiratory diseases | Chellappan, DK; Prasher, P; Shukla, SD; Yee, TW; Kah, TK; Xyan, TW; Kid, TW; Si, TH; Weng, TS; Molugulu, N; Sakthivel, LP; Chellian, J; Madheswaran, T; Malipeddi, H; Singh, Y; Dureja, H; Kapoor, DN; Negi, P; Goyal, R; Thangavelu, L; Kumar, D; Gupta, PK; Jha, NK; Shastri, MD; MacLoughlin, R; Singh, SK; Gulati, M; Gupta, G; Dua, K |
